Clinical Trials in San Diego

Showing 6841-6860 of 14,679 trials

Mentors Offering Maternal Support (M-O-M-S™): A Prenatal Program for Decreasing Maternal Anxiety and Depression

NCT03393637

The M-O-M-S project evaluates the effectiveness of the M-O-M-S program for improving birth outcomes and maternal-infant attachment and role satisfaction in a large military sample.

Anxiety FearPrenatal DepressionInfant, Low Birth Weight+2 more

University of the Incarnate Word1,717 participantsStarted Dec 2017

San Diego, California, United States • San Antonio, Texas, United States • Tacoma, Washington, United States

TERMINATED< 1 mile

Long-term Follow-Up Study Following Treatment With Fate Therapeutics' Engineered Cellular Immunotherapy

NCT04093622

The purpose of the study is to assess long-term side effects from subjects who receive a Fate Therapeutics genetically modified NK cell product. Subjects who previously took part in a Fate Therapeutics study and received genetically changed NK cells will take part in this long-term follow-up study. Subjects will join this study once they complete the parent interventional study. No additional study drug will be given, but subjects can receive other therapies for their cancer while they are being followed for long term safety in this study. For a period of 15 years starting from the last administration of Fate Therapeutics genetically modified NK cell product, subjects will be assessed for long-term safety and survival through questionnaires and blood tests.

Hematological Malignancy

Fate Therapeutics2 participantsStarted Oct 2019

Phoenix, Arizona, United States • San Diego, California, United States • Minneapolis, Minnesota, United States +2 more locations

Mentors Offering Maternal Support (M-O-M-S™): A Prenatal Program for Decreasing Maternal Anxiety and Depression

Long-term Follow-Up Study Following Treatment With Fate Therapeutics' Engineered Cellular Immunotherapy

Find Trials by Condition in San Diego

Safety and Efficacy Study of Botulinum Toxin for the Treatment of Glabellar Frown Lines

Efficacy and Safety of a New Dilution and Injection Volume of AbobotulinumtoxinA for the Treatment of Glabellar Lines

Safety & Effectiveness of Clobex Spray, Followed by Calcitriol Ointment in Management of Plaque Psoriasis

Phase 2 Study on Effects of Obeticholic Acid (OCA) on Lipoprotein Metabolism in Participants With Primary Biliary Cirrhosis

Phase 2 Study to Assess Safety, Tolerability and Efficacy of Once Weekly SC Pemziviptadil (PB1046) in Subjects With Symptomatic PAH

Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Platysmal Bands

Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Glabellar Lines

Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma

To Evaluate the Safety, and Pharmacokinetics of Parscaclisib in Participants With Normal Hepatic Function and Hepatic Impairment.

Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Participants With Presumed Nonalcoholic Steatohepatitis (NASH)

Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors

A Study of Mirikizumab (LY3074828) in Participants With Active Crohn's Disease

A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia

Open-Label Extension and Safety Study of Talazoparib

Study of Cosibelimab in Subjects With Relapsed or Refractory Lymphoma

Efficacy/Safety/Subject Satisfaction/Duration of Response of Clobetasol Propionate Spray vs Ointment in Plaque Psoriasis

Seasonal Influenza HA DNA With Trivalent Inactivated Vaccine (TIV) Administered ID or IM in Healthy Adults 18-70 Years

A Prospective Study of Early Mechanical Stabilization and Bleeding in Disruption of the Pelvic Ring